Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Institutional ownership increased. 16mln purchases above $2 last quarter and only 3mln sales. Great names in there.
(If anyone has any doubt you can go over my previous posts) I posted previously that medical equipment sales takes time as there is existing manufacturer and hospitals need more than just FDA approval, which is hands on experience from other hospitals. We are social animals, we do what others do. ISRG had first mover advantage (econ101). TRXC will slowly eat them away.
TRXC has over 140mln dollars in the bank and no dilution beyond 2019. They are selling faster then preFDA. The more they sell the better Senhance will be sold. So far, 4 in over a year pre-FDA and just in 4 months after FDA approval they sold 4+. 4 for sure already sold. According to BOWA couples of more installations are coming. I talked to one rep, private messaging, he mentioned after Russian FDA approval (expected late March), they already have few pipelines lined up.
Current stock price action? Well I talked about it previously.
It is going down just because it is being heavily shorted not because people selling their positions. There is a major difference here. If it was naturally going down, I would be the first out of my position. Plus, Institutions are smarter then retail. Look at their Trading profits and you will understand what I am saying. There is a fallacy going around, oh Institutions don't make mistakes? Of course they do, they do much much much less than retail investors. I bet with institutions any time of the day, rather than against them.
I dont think current shorters are betting on TRXC demise. It is most likely let's short and accumulate at the bottom. I am really sorry for retail BEARs. Since they have absolutely 0 working thesis. Most likely war will be lost by them. Why? Because, TRXC sales are picking up month after month. FDA approval for more procedures. FL hospital guy posted on FB, how cool it was using Senhance. Surgeons love them. Plus per procedure cost is just 400 on stark contrast to competition. FDA said in their approval that Senhance is no less inferior to DaVinci. Enough said
I am pretty confident we will destroy the 2018 earnings estimate in just 2 quarters. Let's see in 3 months! This board will be transformed to Bulls!
WRONG! Surgeons are buying. Since you have been saying no sales, surgeons don't want it, SENHANCE sold 4 units and more coming this quarter alone...
My bet is where my belief is...
Do your bet and we will see soon who is on the right side. JPMorgan, Blackrock, Vanguard, me or Bear thesis.
TRXC will beat earnings estimate for the 2018 by the end of Q2.
Sales will accelerate from this point on. It is always hard in the beginning. Russian FDA expected in April, and there are two exhibitions of Senhance in April. Russia will buy at least a dozen...
Good time for us longs!
Exactly. Like you couldn't be wrong.
I will open my eyes, if you shut your mouth!
Yes. These doctors and investors know nothing.
Insiders and Funds who have pulse on the company and product still didn't know this. Institutions keep increasing their position.
CEO and CFO knew it all along :)
But look at these 2 directors who have been with the company twice longer and stashed 15mln shares. Perhaps she doesn't know it either.
Dr. Jane H. Hsiao, PhD N/A 15,812,681 7.94% 2013-12-06
Mr. Andrea Biffi N/A 590,000 0.3% 2017-10-16
Aisling Capital LLC Premium Plus 10,335,819 2017-09-30 2.43% 5.19% 14,780
SV Life Sciences Advisers, LLC Premium Plus 7,546,692 2017-09-30 8.18% 3.79% 10,792
MASTERS CAPITAL MANAGEMENT LLC Premium Plus 4,000,000 2017-09-30 0.13% 2.01% 5,720
VANGUARD GROUP INC Premium Plus 3,156,851 2017-09-30 0.00% 1.58% 4,514
StepStone Group LP Premium Plus 3,032,625 2017-09-30 2.87% 1.52% 4,336
CREDIT SUISSE AG/ Premium Plus 1,200,667 2017-09-30 0.00% 0.6% 1,717
BlackRock Inc. Premium Plus 684,133 2017-09-30 0.00% 0.34% 979
GEODE CAPITAL MANAGEMENT, LLC Premium Plus 670,160 2017-09-30 0.00% 0.34% 958
GOLDMAN SACHS GROUP INC Premium Plus 347,500 2017-09-30 0.00% 0.17% 497
ELEMENT CAPITAL MANAGEMENT LLC Premium Plus 249,959 2017-09-30 0.15% 0.13% 357
NORTHERN TRUST CORP Premium Plus 212,334 2017-09-30 0.00% 0.11% 304
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM Premium Plus 161,400 2017-09-30 0.00% 0.08% 231
GOLDMAN SACHS GROUP INC Premium Plus 161,358 2017-09-30 0.00% 0.08% 231
National Planning Corp Premium Plus 159,250 2017-09-30 0.02% 0.08% 228
GROUP ONE TRADING, L.P. Premium Plus 116,349 2017-09-30 0.01% 0.06% 166
AE Wealth Management LLC Premium Plus 106,010 2017-09-30 0.02% 0.05% 152
I have 2 thoughts on this.
1) They are shorting it to load up at the bottom, before TRXC shows strength, which is about 4-6 quarters. It is easy to spook retail investor and collect their shares. ISRG went thru the same. Right after FDA approval stock collapsed from 9 to 2 and Institutional investors collected dirt cheap stocks.
2) Some Hedge Fund/s betting on TRXC demise. Of which I am not really certain. Why? Because real BEARs want to conceal their operation and would like to short higher as possible. However, if you read message boards and read articles of SA, you will see that shorters employing all tactics to drive the price down.
Now on the instruments of achieving 2 of the above goals. Naked selling - I am not sure how much of them are naked shorting. Not a specialist on this. There are ways of hiding it. And the one you have seen 'Fail to Deliver' shows up only if it was asked. While price is going down it won't happen + there are ways of clearing transactions alternatively where 'Failed to Deliver' will never show up. Remember Knight Capital? google their naked shorting, you will see.
Any new business has more chances of failure than success. TRXC is selling Senhance faster than before. I hope they crush the annual earnings by end of Q2 and we will see great spike. I am betting annual salary on this horse (pony?). Time will show if they become successful or not but I don't find any good bear thesis at all. Gibberish all the time. Because no ONE knows the future. Not Bulls and not Bears. Invest and enjoy the ride. GLTY
Here you go
http://regsho.finra.org/regsho-Index.html
Go to Finra/NYSE TRF and open any date you wanna view
You are welcome
LOL. YOur statement is false. Before FDA approval they sold 4 Senhance in a year. Since then they have sold 4; it hasn't been even a year.
Read the statements. It is selling much faster than before
You shouldn't be at all in stock market if you can't even locate it in the file.
It is heavily being shorted. You can look up FINRA REG SHO.
For the last 4 months it has been controlled by shorts. It is a steal at these prices. Either Hedge Funds are playing mind games, eg loading up at lower levels or they are truly betting on TRXC to fail.
Current indications that Senhance is selling much faster after FDA approval. February 14th we will hear some "love stories" from Todd :)
Me too! I think I suck at being sarcastic :)
Bears have 0 credible thesis. TRXC is selling and I hope they crush 2018 revenue forecast by Q2
Yes Pope is Scam. Jane is SCAM too!
Jane works at TRXC for over 13 years and owns over 15mln shares, far more than CEO and served at TRXC twice longer that POPE.
Jane is a scam too because she is waiting to dump this soon. She will dump at $1 to drown us in shares.
Pope worked on this only few years.
Jane H. Hsiao
Independent Director 15,812,681
it is just a short attack. Short attacks go at least 4-9 months as they have to wear down longs so that they sell their shares cheap.
EASY to check my claims. Just go to FINRA REG SHO and check daily short volume. Then see how short interest have risen as well.
I have heard that it is WALL ST betting against. As if it is everyone in wall street. Doesn't make any sense. WHY?
Look at the Inst Ownership, it has risen not fallen. So it is MMs or Hedge Fund or two betting to get retail shares cheaper before any major swing up.
TRXC is not ISRG, however small glance at ISRG history might teach longs a thing or two. ISRG was short attacked right after FDA approval as well and their pps plummeted from 9 to 2. It took a year to get back to that price range. Rest is history
Everyone is entitled to their opinion. Yet I wait to hear good Bear thesis, none exists. My 2 cents
You are absolutely wrong. There was a reference to it.
Did you see CIS sale 1? Go look at it. CIS is former soviet union countries.
Search on FB, BOWA medical
They are distributor from Ukraine. They sold 1 back in December. If they keep selling every month that would be great.
TRXC needs more distribution partners like them
TRXC sold another Senhance! So BEAR thesis of Senhance is a dud falling apart with each sales.
Obviously there is a psychological aspect of it. Traders don't change their mind even when facts are presented - Sunk cost fallacy and this - https://www.newyorker.com/magazine/2017/02/27/why-facts-dont-change-our-minds
Anyway, good for TRXC. The more they sell, the better it will sell. You will see, sales will accelerate.
Because they are not selling lollipops, expensive surgical equipment. Hospitals will go with a proven robot. Senhance keeps proving and it will get more and more willing buyers.
LONGS these prices are a gift to you!
Let's see if Shorts are right or Longs are.
Time and again I have seen tons of bears burn badly, multiples of their investments in the market. Perhaps TRXC will be one of them to them.
Not true at all. Short Volume increased to over 62%
"Sell off" means people holding selling their shares. IT is a short attack which is ongoing for 3 months.
PLUS it is not "accelerating" because AVG volume is 3 times lower than average volume we had last 3 months.
My analysis it is now consolidating and getting to point where slight movement upward will trigger Short Squeeze.
Short interest is 15mln now :)
Would you mind elaborating on your point? "The problem with Senhance as I see it is, based on the videos that I have seen, if the proverbial stool hits the fan,the physical barriers to quick access to the patient are greatly increased by the number of booms required to use this platform."
Doesn't Senhance architecture give freer access to patient compared to DaVinci?
0 sales? They sold 5 Senhance in 2017. They have 1 more pending EU order as well. More hospitals use it more sales will come in.
This is a medical device, no one is going to jump in just like that. Sales teams are needed.
Coca Cola sold 5 bottles in its first year. I don't think it was a junk. Just giving a perspective here.
Partner is a partner! As long as it helps to sell Senhance I am for it.
We will see in an hour if there anything we didn't hear yet.
Senhance doesn't have to be superior to DaVinci. FDA approval speaks enough. It is as safe to use. We have so many different smart phones, if logic is Only Superior will sell, we wouldn't see so many different products in the market.
There is a market for Senhance and it is selling. I just wish TRXC mgmt good luck! We will see great numbers as we roll in to 2-3 quarters.
Solid reversal. Yesterday's short volume was 64.76%. More than half of the sold shares were borrowed and sold with one aim to bring the price down. It didn't work!!! Price went up instead.
Short position needs to be reevaluated when seeing this type of reversals.
Especially there might be a big news at investors conference. 1 Good news is Senhance sold in Kazakhstan, distributor was BOWA Medical. Check it out on their FB page. More news is coming definitely. This will increase smart money flow. According to gurufocus smart money doubled in last quarter.
All above can be easily verified by googling. Always fact check.
Good Luck!
Sell shares? They have $114mln cash at hand which is enough beyond 2018.
What new dilution? At least read the file, no new dilutions. Warrants MIGHT be exercised that became exercisable back in spring.
TRXC being heavily shorted. Abusive shorting ends in tears for bulls who sell cheaply and for bears who don't cover at these prices.
Once SEC regulation for naked short is enforced you will see how the price will shoot up.
Anyone who wants to learn about naked shorting or abusive shorting just google it. Or look L2 full view if your system marks shorting.
Company has huge upside. Shorting this stock is playing with a dynamite.
They sold couple of Senhance. 1 after a month of FDA approval and another in Europe.
Anyway, having more procedures approved will double the market and makes the Senhance more sellable.
January as mentioned TRXC will go up. Buy while it is cheap. Even bears agree TRXC poised to go up!
Even Da Vinci sold in Europe is less than 25% of what ISRG sold in the US. Even though, Da Vinci was approved in EU 2 years before it got approval from FDA in the US.
EU and US markets are largely different. So, scaremongers can keep beating the drum has nothing in common with the reality.
TRXC deserves some time to ramp up their sales. TRXC board of advisors all have positions at hospitals, I believe they will drive the sales back to those hospitals. As more hospitals buy the sales will pick up even faster.
17mln debt is absolutely pittance. Please open any biotech company and look their liabilities. So I have no idea why this point point is being brought up again and again. Unless of course writers of 17mln has ulterior motive as to plant seeds of doubt on new investors who don't know much in investing or trading. Basic comparison will show you that 17mln is not a problem at all.
"Few Years" in Europe. It has not been FEW YEARS. Sehnance was purchased September 2015 and they really started marketing it in 2016 first quarter. Since then they sold 3 pieces in Europe.
FDA clearance will give TRXC more confidence to ramp up sales. FL hospital used Senhance, loved it and bought it. No one buys 1.5mln dollar equipment if it wouldn't benefit them.
More sales are coming! 100mln in cash so 17mln debt got nothing on us. TRXC can pay it off any moment.
doesn't make is less nonsense. Some are indeed in your league
utter nonsense. Any trader just pick 30-40 recent Buy Out or Partnerships and see price before the announcement. It has no correlation - meaning it never has upward trend because of M&A.
In short, price will not move up if M&A isn't announced/there is no leak.
Reading into short term price fluctuations will give a trader the same insight if you just read coffee stains off your cup.
Nope. Sales needs marketing and sales people.
BMW, Mercedez why do you think advertised. Why they have car dealerships with sales people?
TRXC partnerships starting!!! InstruSafe® by Summit Medical Partners with the Senhance™ Surgical Robotic System to Launch Two New Surgical Instrument Trays
http://www.businesswire.com/news/home/20171205005952/en/InstruSafe%C2%AE-Summit-Medical-Partners-Senhance%E2%84%A2-Surgical-Robotic
as if you know everyday why any stock is crashing or going up.
It is called a random walk. Sometimes prices go up and sometimes down on the short term. Long term is the game. Not a daily fluctuations.
I feel sorry for a daytrader, losing game.
TRXC will surprise a lot of people soon and bears will burn big time. Huge risk being taken by shorts for very limited profit. Losers game I would say
TRXC going up and will explode on a good news.
Keep shorting at your own peril. All in all, this is suckers game to short TRXC.
Exposing yourself to huge upward risk. One day Shorts wake up to huge gap up.
For now, relax and watch steady slow climb back to 2.90ish area in few days.
GL to Longs. Shorts burn
Nothing wrong buying it at 3s or 4s. It was hammered down by abusive shorting. Soon it will reverse
BTW, if any BEARs or Bulls burnt on TRXC because of White Diamond Research or Turdeau. You should sue them.
Look at RLYP. They said it is 0. It got acquired to 1.5bln dollars after a month. Just google it.
Or google STRP. They did 'research' on it and said the same. Now it is whopping 380% up.
BEARs used here Streetsweepers and White Diamnod "research" (Prejudice). What a shame. They have 0 credibility.
For longs, do not believe these charlatans. Do your research. Do not trust me or any other person. 5 min googling will show you the reality.
Right now it is too early to make any conclusions if the company will fail. It just got up. Next year end, we will talk. If they don't make it, we tried. If we make it, you will make at least 5 times or even 10times more money. Shorting earns you 10 cents, 20 cents, maybe $1. However, good news wipe you out of your trading account forever. You will be in debt for the rest of your life.
Good luck longs!
TRXC on uptrend. Green all over. Wouldn't you agree BEARs?
Did you read White Diamond, StreetSweeper and Turdeau research (actually 'PREJUDICE') reports and shorted TRXC?
Bad move.
Now you have to cover at higher prices. Word of advise, don't be naked short as TRXC might surprise and you might lose a LOT. Gain not much here from shorting, 10 cents? But if indeed good sales, buyout or partnership... BEARs will lose 10 times more.
Good luck to LONGS!
Too EARLY to judge Senhance. It has been literally 1 month since the approval. SENHANCE will sell.
Let's see their 2nd quarter report in 2018. As you said millions of dollars costing machine and it requires due diligence when there is an existing competitor who was in the market for 20 years with proven track record. :)
I am betting on them making it in the market. YOu are betting on them failing. Fair enough. Let's see and wait. It is too early.
Europe is a different market. Da Vinci was approved 2 years before it was approved in the US in 2000. They sold only 600ish in Europe but 2500ish in the US. Just saying you can't throw in the towel saying, hey they couldn't sell in 2 years after acquiring Senhance. Agreed it was slow, however as I said it is a different market. Just look at what ISRG could sell without competition and being approved over 22 years now.
Anyway, let's see. Smart money is still in. If they leave I will definitely sell but not yet. It is too early to judge. I think they will thrive. Peace!
Which makes it a bit more difficult.
ECON101 - First movers advantage. Here you go https://en.wikipedia.org/wiki/First-mover_advantage
Da Vinci sales had its own difficulties but for Senhance it is even more difficult. WHY? Because when Hospitals are making decision they will have to absolutely sure Senhance is better equipment (more Hospitals using it for longer periods will help TRXC on this point), Second Surgeons who are trained on it (FL hospital is a great place for surgeons to practice and learn. 6 more available in Europe).
So no SPORT. When there is a competition it is a bit difficult.
EVER heard of ALTAVISTA? I used to use it till 1999. Yahoo bought it over GOOGLE. Back then Google was asking only 1mln dollars. The same story they were second coming to the market. Just let's see what the sales number be. Fingers crossed and I believe in the product. Since Japan and Taiwan buying Senhance without any approval tells A LOT. What it does tell? It tells that they like the product and sure that TRXC will get the approval and they will use it for surgeries.
I rest my case. It is very very VERY dangerous being naked short on this stock. As I said 1000 times no one knows the future however all tell tale signs that SENHANCE will succeed.
4 major catalysts will break Bears!!! Bears act so caring and smarter than Professional Analysts!
Your agenda is just scare and steal shares cheaply which is low.
Longs invest and take risks so that companies can survive and contribute to our living standards.
Anyway, there are 4 major catalysts coming:
In December:
1) EU Sale announcement
2) 3mm instrument sales start in Europe
In January:
1) FDA submission for more procedures, doubles the current market coverage of Senhance
2) 3mm Instrument sales in the US
Selling equipment takes time. ISRG Sold only 1 Da Vinci after approval in their 4th quarter in 2000 in the US. Go look up!
Old bashing, no news here.
She just regurgitated what Seeking Alpha said. How is it contributing anything new?
Amanda has done the same thing in the past. Disgrace to journalism.